GlassScriptPhysician profile
Wendy Blagg Demko
NPI 1780926378
$5,276.52
in general payments reported to CMS, 2019-2025
28 companies · $1,675 in 2025
The $1,675 reported for 2025 was more than what 91% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $315 · 2023: $1,436 · 2024: $1,851 · 2025: $1,675.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,867 · Education: $94.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,867.02 |
| Education | $94.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $959.24 | 2022-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $850.06 | 2022-2025 | Farxiga, Breztri |
| Amgen INC. | $397.33 | 2023-2025 | Evenity, Prolia, Repatha |
| Pfizer INC. | $339.28 | 2023-2025 | |
| Lilly USA, LLC | $327.58 | 2022-2025 | Mounjaro, Zepbound, Kisunla |
| Bayer Healthcare Pharmaceuticals INC. | $305.97 | 2022-2025 | |
| Eisai INC. | $271.19 | 2023-2025 | |
| Exact Sciences Corporation | $199.05 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Boehringer Ingelheim Pharmaceuticals, INC. | $188.29 | 2022-2025 | Jardiance, Synjardy, Tradjenta |
| Abbvie INC. | $182.18 | 2024-2025 | |
| Astellas Pharma US INC | $173.11 | 2024-2025 | Veozah |
| Merck Sharp & Dohme LLC | $137.65 | 2022-2024 | Verquvo, Belsomra, Steglatro |
| Glaxosmithkline, LLC. | $135.69 | 2023-2025 | Arexvy, Trelegy Ellipta, Shingrix |
| Sanofi-Aventis U.S. LLC | $108.42 | 2024-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $100.52 | 2023-2025 | Xifaxan, Trulance |
Show all 28 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $99.77 | 2023-2025 | Freestyle Libre 3 |
| Novartis Pharmaceuticals Corporation | $77.90 | 2025 | |
| Corium, LLC | $67.71 | 2022-2024 | Azstarys |
| Janssen Pharmaceuticals, INC | $60.66 | 2023-2024 | Xarelto |
| Takeda Pharmaceuticals U.S.A., INC. | $51.52 | 2023-2025 | Trintellix |
| Lundbeck LLC | $49.03 | 2025 | Rexulti |
| Idorsia Pharmaceuticals US INC | $46.44 | 2023-2024 | Quviviq |
| Corcept Therapeutics | $33.93 | 2025 | Korlym |
| Alnylam Pharmaceuticals INC. | $29.31 | 2025 | Givlaari |
| Insmed, INC. | $23.68 | 2025 | Brinsupri, Arikayce |
| Medtronic, INC. | $22.54 | 2025 | Intellis Adaptivestim |
| Ironshore Pharmaceuticals INC. | $19.88 | 2023 | Jornay Pm |
| Inspire Medical Systems, INC. | $18.59 | 2025 | Inspire |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Wendy Demko listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.